Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Madison, Russell"'
Autor:
Rolfo CD; Center of Thoracic Oncology at The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Madison RW; Foundation Medicine, Inc., Cambridge, Massachusetts., Pasquina LW; Foundation Medicine, Inc., Cambridge, Massachusetts., Brown DW; Foundation Medicine, Inc., Cambridge, Massachusetts., Huang Y; Foundation Medicine, Inc., Cambridge, Massachusetts., Hughes JD; Foundation Medicine, Inc., Cambridge, Massachusetts., Graf RP; Foundation Medicine, Inc., Cambridge, Massachusetts., Oxnard GR; Foundation Medicine, Inc., Cambridge, Massachusetts., Husain H; Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jun 03; Vol. 30 (11), pp. 2452-2460.
Autor:
Pellini B; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida., Madison RW; Foundation Medicine, Inc., Cambridge, Massachusetts., Childress MA; Foundation Medicine, Inc., Cambridge, Massachusetts., Miller ST; Foundation Medicine, Inc., Cambridge, Massachusetts., Gjoerup O; Foundation Medicine, Inc., Cambridge, Massachusetts., Cheng J; Genentech, Inc., South San Francisco, California., Huang RSP; Foundation Medicine, Inc., Cambridge, Massachusetts., Krainock M; Natera, Inc., San Carlos, California., Gupta P; Genentech, Inc., South San Francisco, California., Zou W; Genentech, Inc., South San Francisco, California., Shames DS; Genentech, Inc., South San Francisco, California., Moshkevich S; Natera, Inc., San Carlos, California., Ballinger M; Genentech, Inc., South San Francisco, California., Liu MC; Natera, Inc., San Carlos, California., Young A; Foundation Medicine, Inc., Cambridge, Massachusetts., Srivastava MK; Genentech, Inc., South San Francisco, California., Oxnard GR; Foundation Medicine, Inc., Cambridge, Massachusetts., Socinski MA; AdventHealth Cancer Institute, Orlando, Florida.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Nov 14; Vol. 29 (22), pp. 4596-4605.
Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast Carcinoma.
Autor:
Rugo HS; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Raskina K; Foundation Medicine Inc., Cambridge, Massachusetts., Schrock AB; Foundation Medicine Inc., Cambridge, Massachusetts., Madison RW; Foundation Medicine Inc., Cambridge, Massachusetts., Graf RP; Foundation Medicine Inc., Cambridge, Massachusetts., Sokol ES; Foundation Medicine Inc., Cambridge, Massachusetts., Sivakumar S; Foundation Medicine Inc., Cambridge, Massachusetts., Lee JK; Foundation Medicine Inc., Cambridge, Massachusetts., Fisher V; Foundation Medicine Inc., Cambridge, Massachusetts., Oxnard GR; Foundation Medicine Inc., Cambridge, Massachusetts., Tukachinsky H; Foundation Medicine Inc., Cambridge, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Mar 14; Vol. 29 (6), pp. 1056-1067.
Autor:
Lee JK, Hazar-Rethinam M, Decker B, Gjoerup O, Madison RW, Lieber DS, Chung JH, Schrock AB, Creeden J, Venstrom J, Alexander B, Oxnard GR
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Feb 15; Vol. 28 (4), pp. 728-737.
Autor:
Tukachinsky H; Foundation Medicine Inc., Cambridge, Massachusetts., Madison RW; Foundation Medicine Inc., Cambridge, Massachusetts., Chung JH; Foundation Medicine Inc., Cambridge, Massachusetts., Gjoerup OV; Foundation Medicine Inc., Cambridge, Massachusetts., Severson EA; Foundation Medicine Inc., Cambridge, Massachusetts., Dennis L; Foundation Medicine Inc., Cambridge, Massachusetts., Fendler BJ; Foundation Medicine Inc., Cambridge, Massachusetts., Morley S; Foundation Medicine Inc., Cambridge, Massachusetts., Zhong L; Foundation Medicine Inc., Cambridge, Massachusetts., Graf RP; Foundation Medicine Inc., Cambridge, Massachusetts., Ross JS; Foundation Medicine Inc., Cambridge, Massachusetts.; Upstate Medical University, Syracuse, New York., Alexander BM; Foundation Medicine Inc., Cambridge, Massachusetts., Abida W; Memorial Sloan Kettering Cancer Center, New York, New York., Chowdhury S; Guy's, King's, and St. Thomas' Hospital, London, England, United Kingdom., Ryan CJ; University of Minnesota Medical School, Minneapolis, Minnesota., Fizazi K; Institut Gustave Roussy, Villejuif, France., Golsorkhi T; Clovis Oncology, Boulder, Colorado., Watkins SP; Clovis Oncology, Boulder, Colorado., Simmons A; Clovis Oncology, Boulder, Colorado., Loehr A; Clovis Oncology, Boulder, Colorado., Venstrom JM; Foundation Medicine Inc., Cambridge, Massachusetts., Oxnard GR; Foundation Medicine Inc., Cambridge, Massachusetts. goxnard@foundationmedicine.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jun 01; Vol. 27 (11), pp. 3094-3105. Date of Electronic Publication: 2021 Feb 08.
Autor:
Papadopoulos KP; South Texas Accelerated Research Therapeutics, San Antonio, Texas., Borazanci E; HonorHealth and Translational Genomics Research Institute, Scottsdale, Arizona., Shaw AT; Novartis Institute of BioMedical Research, Cambridge, Massachusetts.; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Katayama R; Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan., Shimizu Y; Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan., Zhu VW; Chao Family Comprehensive Cancer Center, University of California, Irvine School of Medicine, Orange, California., Sun TY; Department of Medicine, Division of Oncology, Stanford University, Stanford Cancer Institute, Stanford, California., Wakelee HA; Department of Medicine, Division of Oncology, Stanford University, Stanford Cancer Institute, Stanford, California., Madison R; Foundation Medicine Inc, Cambridge, Massachusetts., Schrock AB; Foundation Medicine Inc, Cambridge, Massachusetts., Senaldi G; Daiichi Sankyo, Inc., Basking Ridge, New Jersey., Nakao N; Daiichi Sankyo RD Novare Co., Ltd, Tokyo, Japan., Hanzawa H; Daiichi Sankyo RD Novare Co., Ltd, Tokyo, Japan., Tachibana M; Daiichi Sankyo, Co., Ltd, Tokyo, Japan., Isoyama T; Daiichi Sankyo, Co., Ltd, Tokyo, Japan., Nakamaru K; Daiichi Sankyo, Co., Ltd, Tokyo, Japan., Deng C; Linking Truth Technology Co, Ltd, Beijing, China., Li M; AnHeart Therapeutics (Hangzhou) Company Ltd, Hangzhou, Zhejiang province, China., Fan F; AnHeart Therapeutics (Hangzhou) Company Ltd, Hangzhou, Zhejiang province, China., Zhao Q; AnHeart Therapeutics (Hangzhou) Company Ltd, Hangzhou, Zhejiang province, China., Gao Y; AnHeart Therapeutics (Hangzhou) Company Ltd, Hangzhou, Zhejiang province, China., Seto T; Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Jänne PA; Dana-Faber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Ou SI; Chao Family Comprehensive Cancer Center, University of California, Irvine School of Medicine, Orange, California. siou@hs.uci.edu.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Sep 15; Vol. 26 (18), pp. 4785-4794. Date of Electronic Publication: 2020 Jun 26.